353 related articles for article (PubMed ID: 17452977)
21. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
23. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J
Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255
[TBL] [Abstract][Full Text] [Related]
24. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
25. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
Kim MK; Carroll WL
Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.
Montgomery RL; Davis CA; Potthoff MJ; Haberland M; Fielitz J; Qi X; Hill JA; Richardson JA; Olson EN
Genes Dev; 2007 Jul; 21(14):1790-802. PubMed ID: 17639084
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes.
Kasler HG; Verdin E
Mol Cell Biol; 2007 Jul; 27(14):5184-200. PubMed ID: 17470548
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
[TBL] [Abstract][Full Text] [Related]
29. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis.
Knosp WM; Scott V; Bächinger HP; Stadler HS
Development; 2004 Sep; 131(18):4581-92. PubMed ID: 15342482
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
31. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
[TBL] [Abstract][Full Text] [Related]
32. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
[TBL] [Abstract][Full Text] [Related]
33. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
34. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.
Fritsche P; Seidler B; Schüler S; Schnieke A; Göttlicher M; Schmid RM; Saur D; Schneider G
Gut; 2009 Oct; 58(10):1399-409. PubMed ID: 19528037
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.
Brunmeir R; Lagger S; Seiser C
Int J Dev Biol; 2009; 53(2-3):275-89. PubMed ID: 19412887
[TBL] [Abstract][Full Text] [Related]
36. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Keating J; Sekyere E; Jonquieres G; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T
Oncogene; 2010 Nov; 29(44):5957-68. PubMed ID: 20697349
[TBL] [Abstract][Full Text] [Related]
38. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
39. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC
Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
